eFFECTOR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 169.3%.

Top 25 shareholders own 16.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.22%	Abingworth LLP	192,884	€2.4m	0%	0.71%
2.48%	Altitude Life Science Ventures	113,054	€1.4m	0%	100.0%
2.09%	Sectoral Asset Management Inc.	95,305	€1.2m	0%	0.18%
1.65%	Pfizer Inc.	75,152	€953.2k	0%	no data
1.48%	Parallel Advisors, LLC	67,742	€859.2k	0%	0.02%
1.15%	Blackstone Inc.	52,343	€663.9k	0%	no data
0.9%	Oup Management Co., LLC	41,027	€520.4k	0%	0.92%
0.73%	Stephen Worland	33,182	€420.9k	0.73%	no data
0.5%	The Vanguard Group, Inc.	22,976	€291.4k	42.2%	no data
0.36%	Geode Capital Management, LLC	16,318	€207.0k	54.7%	no data
0.32%	Pfizer Venture Investments LLC	14,602	€185.2k	-83.7%	4.01%
0.14%	Northern Trust Global Investments	6,432	€81.6k	337%	no data
0.11%	Sonora Investment Management Group, LLC	5,000	€63.4k	0%	0.01%
0.088%	Sabby Management, LLC	4,000	€50.7k	0%	0.26%
0.054%	Two Sigma Securities, LLC, Asset Management Arm	2,467	€31.3k	0%	no data
0.043%	Alana McNulty	1,951	€24.7k	0%	no data
0.038%	Michael Byrnes	1,731	€22.0k	11.7%	no data
0.032%	Christopher Ehrlich	1,450	€18.4k	0%	no data
0.031%	InterWest Partners LLC	1,409	€17.9k	0%	0.02%
0.027%	State Street Global Advisors, Inc.	1,235	€15.7k	53.8%	no data
0.027%	Wescott Financial Advisory Group LLC	1,222	€15.5k	0%	no data
0.026%	Brian Gallagher	1,200	€15.2k	0%	no data
0.021%	John Smither	966	€12.3k	0%	no data
0.02%	Stifel Asset Management Corp.	906	€11.5k	0%	no data
0.018%	Callan Capital, LLC	800	€10.2k	0%	no data